Teledyne to Acquire Varex Imaging Corporation
Teledyne Technologies agreed to acquire Varex Imaging in a cash deal for $18.90 per Varex share, valuing the transaction at about $1.1 billion including equity awards and net debt as of April 3, 2026. Boards approved unanimously. Closing is expected in early 2027, pending regulatory and Varex stockholder approvals.
How this was made
The 30-second read
Why it matters
The definitive agreement with a stated cash price and total value creates immediate repricing and merger-arb opportunities, while the early-2027 closing target highlights a long approval runway.
Market read
Definitive M&A terms (cash price, total value, unanimous board approval, and closing window) are actionable for both TDY and VREX, especially for deal-spread and approval-probability trading.
What to watch
Merger-arb pricing will hinge on financing structure, antitrust/regulatory review path, and whether any material Varex customer programs are at risk during the approval period.
Background
Teledyne has previously expanded into healthcare imaging via Teledyne DALSA (2011) and Teledyne e2v (2017); Varex is a complementary X-ray sources and detector supplier.
Ticker impact
Teledyne agreed to acquire Varex for $18.90 per share in cash, valuing the deal at about $1.1 billion including net debt and equity awards.
Likely near-term volatility around deal terms, financing expectations, and deal-approval probability; direction depends on perceived strategic fit and deal risk.
The article discloses definitive acquisition price, consideration structure (cash), total value, and timing/conditions, which typically drives immediate repricing and spreads into merger-arb positioning.
Varex entered a definitive agreement to be acquired by Teledyne for $18.90 per share in cash, implying a premium and a clear path to exit subject to approvals.
Shares may trade toward deal value with merger-arb dynamics, but can swing on regulatory/stockholder-approval headlines.
The article provides the per-share cash price, total transaction value, unanimous board approval, and expected completion window, which are the key inputs for deal-spread trading.
Market effects
Could re-rate the medical imaging and X-ray detector supply chain by signaling consolidation and potential product roadmap acceleration.
Primarily US-listed merger dynamics; limited direct regional spillover beyond industrial/healthcare suppliers.
X-ray imaging equipment demand is global, so integration plans and customer adoption could affect international OEM procurement cycles.
Counterpoint
The deal premium may not fully compensate for regulatory risk, integration execution risk, or customer qualification timelines for next-generation detectors.
Key entities
- acquirerTeledyne Technologies Incorporated
Agreed to acquire Varex for $18.90 per share in cash; deal value about $1.1 billion including net debt and equity awards.
- targetVarex Imaging Corporation
Agreed to be acquired; boards approved unanimously; transaction subject to regulatory approvals and Varex stockholder approval.
- executiveRobert Mehrabian
Executive Chairman of Teledyne, cited complementary product positioning and minimal overlap.
- executiveSunny Sanyal
CEO of Varex, highlighted premium and acceleration of advanced imaging adoption.
